ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2692

Individualized Strength, Mobility and Aerobic Rehabilitation Training in axial Spondyloarthritis (iSMART in axSpA)

Sophie De Mits1, Tine Willems2, Lieven Danneels2, Patrick Calders2, Gaëlle Varkas3, Filip Van den Bosch4, Dirk Elewaut5 and Philippe Carron6, 1Ghent University Hospital, Gent, Belgium, 2Ghent University, Gent, Belgium, 3Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 4Department of Internal Medicine and Pediatrics, Ghent University and VIB Center for Inflammation Research, Ghent, Belgium, 5VIB Center for Inflammation Research, and Ghent University Hospital, Department of Rheumatology, Ghent, Belgium, 6Ghent University and VIB Center for Inflammation Research, Ghent, Belgium

Meeting: ACR Convergence 2025

Keywords: clinical trial, exercise, Muscle strength, Rehabilitation, spondyloarthritis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Wednesday, October 29, 2025

Title: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment II: Pathogenesis, Exercise, and Dietary Interventions (2687–2692)

Session Type: Abstract Session

Session Time: 12:45PM-1:00PM

Background/Purpose: AxSpA primarily affects the sacroiliac joints and spine, reducing trunk strength, mobility, and cardiorespiratory fitness. While exercise is a key treatment, few studies have examined combined trunk mobility and strength training with cardiorespiratory training. This prospective interventional study assessed the benefits of a combined and personalized exercise intervention based on baseline physical tests.

Methods: Participants with AxSpA completed a baseline maximal Cardiopulmonary Exercise Test (CPET) and trunk strength/mobility tests using David Back Concept (DBC) devices. Strength and mobility deficits were calculated as: (Reference − Patient value) × 100 / Reference. BASDAI, BASFI, BASMI, and chest expansion (CE) were registered pre- and post-intervention. The 8-week program consists of two weekly sessions of two 10-minute intervals of cardiorespiratory training at a set heart rate (HR), followed by DBC device exercises. Cardiorespiratory intensity was based on ventilatory threshold 1 (VT1) and monitored via a Polar HR device. Trunk training focused on mobility and resistance using each patient’s one-repetition-maximum and maximal range of motion at baseline. All sessions were supervised to ensure correct execution and safety. Post-intervention, CPET and DBC tests were repeated. Linear mixed models analyzed changes over time.

Results: Thirty axSpA patients (14M/16F, age 42±11.2 years; BASDAI 3.5±2.1, BASFI 2.8±2.2, BASMI 2.0±1.1, CE 4.5±2.0 cm) participated; 2 patients were lost to follow-up (1: flare, 2: personal reasons). Strength increased on average by 14.1% (p< 0.001), and mobility improved by 14.9% (p< 0.001) on average, with significant time and direction effects.(See Fig.1) Cardiorespiratory parameters improved significantly: oxygen pulse (p=0.004), ventilatory efficiency (p< 0.001), anaerobic threshold (p=0.002), and mechanical efficiency (p=0.021), but not efficiency slope (p=0.888). (See Table 1) BASDAI (2.9±2.2, p=0.021) and CE (5.0±2.1 cm, p=0.020) showed significant improvement, while BASMI (1.8±1.0, p=0.053) showed a borderline significant decrease and BASFI (2.4±2.1, p=0.092) did not differ significantly. (See Table 2)

Conclusion: A combined, individually tailored exercise program, dependent on baseline objectively measured physical parameters, significantly improved cardiorespiratory fitness, trunk strength, and mobility in AxSpA patients. These results support the role of individualized exercise interventions in enhancing patient outcomes and reducing functional limitations.

Supporting image 1Fig.1: Mean strength (A) and mobility (B) deficit before and after the training program for the different directions.

Supporting image 2Table 1: cardiorespiratory parameters before and after intervention

Supporting image 3Table 2: clinical parameters before and after intervention


Disclosures: S. De Mits: None; T. Willems: None; L. Danneels: None; P. Calders: None; G. Varkas: AbbVie, 2, 5, 6, Amgen, 2, 6, Celltrion, 2, 5, 6, EG, 5, Eli Lilly, 2, 6, Galapagos, 2, 5, 6, Janssen, 2, 6, MSD, 5, Novartis, 2, 6, Pfizer, 2, 5, 6, Takeda, 5, UCB, 2, 6; F. Van den Bosch: AbbVie, 2, 6, Alfasigma, 2, Amgen, 2, 6, Eli Lilly, 2, Galapagos, 2, Grey Wolf Therapeutics, 2, Janssen, 2, 6, Merck, 6, Novartis, 2, 6, Pfizer, 2, 6, UCB, 2, 6; D. Elewaut: AbbVie, 2, 6, Eli Lilly, 2, 6, Galapagos, 2, 6, Novartis, 2, 6, UCB, 2, 6; P. Carron: AbbVie/Abbott, 2, 6, Alfasigma, 2, 6, Bristol-Myers Squibb(BMS), 2, 6, Eli Lilly, 2, 6, Johnson & Johnson, 2, 6, Novartis, 2, 6, UCB, 2, 6.

To cite this abstract in AMA style:

De Mits S, Willems T, Danneels L, Calders P, Varkas G, Van den Bosch F, Elewaut D, Carron P. Individualized Strength, Mobility and Aerobic Rehabilitation Training in axial Spondyloarthritis (iSMART in axSpA) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/individualized-strength-mobility-and-aerobic-rehabilitation-training-in-axial-spondyloarthritis-ismart-in-axspa/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/individualized-strength-mobility-and-aerobic-rehabilitation-training-in-axial-spondyloarthritis-ismart-in-axspa/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology